)
Naim Nazef
Head of Oligonucleotide Chemistry and Delivery Platforms,
Takeda Pharmaceuticals
Innovative and successful leader in oligonucleotide (ASO and siRNA) drug discovery and development from early stage screening and lead optimization to clinical GMP drug supply. Led the successful discovery and development of oligonucleotide delivery platforms including GalNAc, lipid, mAb, peptide and LNPs. Passionate about developing novel targeted oligonucleotide delivery approaches to fully realize the human therapeutic potential of oligonucleotides.